Greg George writes: "In a move that has baffled pain management doctors, the FDA has decided to restrict distribution of a newly approved pain killer. The drug called Onsolis is a short acting but powerful fentanyl pain killer. The drug was originally to be used for acute pain management and end of life pain control. However, the FDA changes now make it very difficult to gain access to the drug for home and institutional settings. The FDA asked 24 companies that make powerful pain killers to develop plans to reduce overdoses. This plan has come down to reducing the number of people that have access to the drugs rather than letting doctors decide the best course of action for each patient."